Physician profile
Robert A Cagle
NPI 1063707313
$29,430.53
in general payments reported to CMS, 2019-2025
20 companies · $1,532 in 2025
The $1,532 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $1,146 · 2021: $1,212 · 2022: $1,965 · 2023: $2,462 · 2024: $6,498 · 2025: $1,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,564 · Food and Beverage: $2,868 · Education: $59.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,564.47 |
| Food and Beverage | $2,867.85 |
| Education | $59.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $11,271.07 | 2019-2025 | Mako, Motionsense Digital Goniometer, Variax |
| Medical Device Business Services, INC. | $5,781.10 | 2019 | |
| Microport Orthopedics INC | $4,319.23 | 2022-2024 | Mpo Medial Pivot Knee |
| Zimmer Biomet Holdings, INC. | $3,259.52 | 2019-2025 | Persona, Avenir, Rosa |
| Conformis, INC. | $2,105.03 | 2019-2020 | |
| Depuy Synthes Sales INC. | $818.29 | 2019-2024 | Na |
| Medtronic USA, INC. | $631.26 | 2019-2020 | |
| Steelhead Surgical INC | $500.24 | 2019 | |
| Smith+Nephew, INC. | $168.45 | 2022-2023 | Legion Revision, Real Intelligence, Journey II |
| Ferring Pharmaceuticals INC. | $139.24 | 2021-2023 | Euflexxa |
| Heron Therapeutics, INC. | $130.01 | 2022-2025 | Zynrelef |
| Evolution Surgical, INC | $125.16 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $59.81 | 2020-2023 | Iovera, Exparel, Zilretta |
| Pacira Therapeutics, INC. | $32.95 | 2019-2021 | |
| Fidia Pharma USA INC. | $17.55 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $15.77 | 2019 | |
| Medtronic Vascular, INC. | $15.17 | 2019 | |
| Bioventus LLC | $14.79 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.89 | 2019 | |
| Heraeus Medical, LLC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cagle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.